The human liver microenvironment shapes the homing and function of CD4
T lymphocytes
cellular immunity
hepatitis B
immunology
liver immunology
Journal
Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
09
12
2020
accepted:
19
08
2021
pubmed:
23
9
2021
medline:
10
6
2022
entrez:
22
9
2021
Statut:
ppublish
Résumé
Tissue-resident memory T cells (T We used multiparametric flow cytometry, histological assessment and novel human tissue coculture systems to interrogate the ex vivo phenotype, function and generation of the intrahepatic CD4 Hepatic CD4 High and intermediate CD69 expressions mark human hepatic CD4
Identifiants
pubmed: 34548339
pii: gutjnl-2020-323771
doi: 10.1136/gutjnl-2020-323771
pmc: PMC9185819
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1399-1411Subventions
Organisme : MRF
ID : MRF_MRF-044-0004-F-GILL-C0823
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-044-0005-F-TRIV-C0824
Pays : United Kingdom
Organisme : Department of Health
ID : PB-PG-0614-34087
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107389/Z/15/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 26813
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-169-0001-F-STAM-C0826
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: BW collaborated with and received funding from Bioniz. LJP sat on advisory boards/provided consultancy for Gilead Sciences and SQZ Biotech. KA was funded by a studentship with Dr Falk. MKM received research funding from Gilead Sciences, Hoffmann La Roche and Immunocore. MKM sat on advisory boards/provided consultancy for Gilead, Hoffmann La Roche, Immunocore, VIR, Galapagos NV, GSK, Abbvie and Freeline. ZS collaborated with Bioniz and AstraZeneca and consulted for Boehringer Ingelheim. All other authors declare no conflict of interest.
Références
Sci Transl Med. 2015 Mar 18;7(279):279ra39
pubmed: 25787765
J Immunol. 2011 Dec 1;187(11):5510-4
pubmed: 22058417
Dig Dis. 2010;28(1):31-44
pubmed: 20460888
Sci Transl Med. 2015 Jan 7;7(269):269rv1
pubmed: 25568072
Gut. 2019 Aug;68(8):1493-1503
pubmed: 30487267
J Exp Med. 2019 May 6;216(5):1214-1229
pubmed: 30923043
J Clin Exp Hepatol. 2013 Mar;3(1):50-60
pubmed: 25755471
Immunity. 2016 Aug 16;45(2):442-56
pubmed: 27521270
Cell Rep. 2018 Apr 17;23(3):768-782
pubmed: 29669283
Immunity. 2016 Dec 20;45(6):1270-1284
pubmed: 27939671
Clin Exp Immunol. 2019 Aug;197(2):143-152
pubmed: 31038727
Mucosal Immunol. 2018 May;11(3):654-667
pubmed: 29139478
J Infect Dis. 2014 Nov 1;210(9):1508-16
pubmed: 24823625
Nature. 2017 Mar 9;543(7644):252-256
pubmed: 28219080
Cell Rep. 2017 Sep 19;20(12):2921-2934
pubmed: 28930685
J Hepatol. 2007 Oct;47(4):598-607
pubmed: 17692984
Age (Dordr). 2009 Dec;31(4):285-91
pubmed: 19479342
J Virol. 2007 Aug;81(16):8468-76
pubmed: 17553885
PLoS Biol. 2005 Apr;3(4):e113
pubmed: 15799695
Int Immunol. 1996 May;8(5):765-72
pubmed: 8671665
Sci Rep. 2016 May 23;6:26157
pubmed: 27210614
Nat Rev Immunol. 2016 Feb;16(2):79-89
pubmed: 26688350
Front Immunol. 2014 Jun 19;5:294
pubmed: 24995010
Nat Immunol. 2013 Dec;14(12):1285-93
pubmed: 24162775
Nat Immunol. 2013 May;14(5):509-13
pubmed: 23542740
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
Nat Commun. 2016 May 10;7:11514
pubmed: 27160938
Semin Immunol. 2012 Jun;24(3):175-89
pubmed: 22444422
Cell. 2014 Nov 6;159(4):814-28
pubmed: 25417158
Expert Rev Mol Med. 2002 Feb 12;4(2):1-16
pubmed: 14987382
Immunity. 2015 Dec 15;43(6):1101-11
pubmed: 26682984
Immunol Today. 1994 Oct;15(10):479-83
pubmed: 7945773
PLoS One. 2011 Jan 26;6(1):e16245
pubmed: 21298112
Sci Immunol. 2017 Mar;2(9):
pubmed: 28707003
Immunity. 2013 Jan 24;38(1):187-97
pubmed: 23260195
Proc Assoc Am Physicians. 1997 Jul;109(4):372-82
pubmed: 9220535
J Exp Med. 2000 Apr 17;191(8):1269-80
pubmed: 10770795
Sci Immunol. 2020 Mar 6;5(45):
pubmed: 32144185
Hepatol Commun. 2018 Nov 15;3(1):8-19
pubmed: 30619990
Cancer Discov. 2016 Oct;6(10):1182-1195
pubmed: 27531854
Sci Immunol. 2019 Apr 5;4(34):
pubmed: 30952804
Immunity. 2016 Oct 18;45(4):889-902
pubmed: 27692609
Nature. 2012 Feb 29;483(7388):227-31
pubmed: 22388819
J Exp Med. 2017 Jun 5;214(6):1567-1580
pubmed: 28526759
Toxicol Sci. 2010 Jun;115(2):307-21
pubmed: 20071422
J Immunol. 2005 Jan 15;174(2):1055-62
pubmed: 15634930
Nat Med. 2015 Jul;21(7):688-97
pubmed: 26121195
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32602903
Front Immunol. 2014 Jul 14;5:331
pubmed: 25071787
J Immunol. 2015 Jul 1;195(1):203-9
pubmed: 26026054